My Medical Gateway Blog

UK patients are increasingly turning to private healthcare, self-pay treatment and overseas medical providers as NHS waiting lists remain high and private health insurance costs continue to rise. New data shows growing numbers bypassing the NHS for faster diagnosis, surgery and specialist care. With millions waiting for treatment and insurance premiums climbing into the thousands, patients are making more pragmatic choices about accessing healthcare, including seeking affordable, high-quality treatment abroad.

The behaviour of UK patients is changing in ways that would have been unthinkable even five years ago. Faced with sustained NHS delays and the rising cost of private healthcare, patients are no longer waiting passively. They are acting, paying and increasingly making independent decisions about how and where they access treatment.

This shift is being driven by two converging forces: the scale of NHS waiting lists and the changing economics of private medical insurance.

On the first, the numbers are stark. An Office for National Statistics (ONS) survey found that 21 per cent of adults in England are waiting for NHS care, equivalent to around 9.7 million people. This is not a marginal backlog. It reflects a structural imbalance between demand and capacity that has persisted for several years.

The response from patients has been immediate and measurable. New data published in March 2026 by Healthwatch England shows that 16 per cent of people used private healthcare in 2025, up from 9 per cent in 2023. Crucially, 39 per cent of those patients said they went private because NHS waiting times were too long.

At the same time, private sector activity has reached record levels. There were 898,000 private hospital admissions in 2023, alongside a 39 per cent increase in self-pay treatments compared to pre-pandemic levels. Patients are no longer relying on the NHS as their sole pathway to treatment. 

But the second driver is just as important and far less understood: the changing reality of private health insurance. Around 7 to 8 million people in the UK have private medical insurance, representing roughly 12 to 14 per cent of the population. Even at peak levels, the vast majority of UK patients have never been covered.

At first glance, private insurance can appear relatively affordable. Headline figures suggest family policies in the low thousands per year. But these averages mask the real experience of long-term policyholders. In practice, premiums rise sharply with age, utilisation and breadth of cover. For many families in their fifties, particularly those with comprehensive cover, annual premiums can run into several thousand pounds. For a healthy family of two adults in their mid-50s and one teenage child with no claims history, total costs may easily reach up to £10,000 per year.

This is not an outlier. It is the lived reality for many of the people who rely most on private healthcare. The result is a growing disconnect between perceived value and actual cost. Patients who have paid into the system for years are increasingly asking a simple question: does this still make financial sense?

For many, the answer is no. Instead of committing to high and rising annual premiums, patients are choosing to fund treatment directly when the need arises. This is the shift towards self-pay.

In many cases, it is a rational calculation. A single self-funded procedure, even at several thousand pounds, can compare favourably to multiple years of insurance premiums. This is particularly true for one-off interventions such as orthopaedic surgery, diagnostics or elective procedures.

This behavioural change is now visible across the system. ONS data shows that 27.7 per cent of adults using private dental services do so because NHS appointments are unavailable, highlighting how patients are already bypassing traditional pathways. The same pattern is emerging across diagnostics, where patients are paying directly for scans and consultations in order to accelerate their care. They are no longer willing to wait in uncertainty. 

The most significant extension of this behaviour is happening beyond the UK. Medical travel is becoming a mainstream response not only to NHS delays but also to the cost structure of UK private healthcare. According to the ONS, more than 520,000 UK patients are estimated to have travelled abroad for treatment in 2025, seeking faster access and better value. That number has been growing year on year.

The procedures being sought are routine: hip replacements, knee surgery, cataracts and dental care. The decision is driven by three factors: speed, cost and confidence in clinical quality. In many cases, treatment abroad is both faster and more cost-effective than UK private provision. When combined with the declining value proposition of insurance for some patients, the case becomes increasingly compelling.

Taken together, these trends point to a fundamental shift. The NHS is no longer the sole pathway through which patients access care. Nor is private insurance the default alternative.  Instead, a multi-channel model is emerging. Patients are moving between NHS services, UK private providers, self-pay diagnostics and international hospitals depending on urgency, affordability and availability.

This is not fragmentation so much as a rational adaptation and, importantly, the shift is being driven by patients themselves.  Faced with waiting lists affecting close to one in five adults in England, individuals are taking control of their healthcare journey. They are comparing options, assessing trade-offs and making decisions that would have been rare a decade ago.

The implications are clear. Private healthcare is being redefined. It is no longer synonymous with insurance. Increasingly, it means self-pay, targeted and used when needed.  Cross-border care is becoming normalised. As more patients travel for treatment, the perceived risk declines and the pathway becomes established.

And waiting is no longer accepted as inevitable. It is treated as a problem to be solved. This is precisely the environment in which MMG operates.

MMG is not creating a new behaviour. It is structuring one that already exists at scale. Patients are already leaving NHS pathways when delays become unacceptable. They are already paying privately. They are already travelling abroad. What MMG provides is clarity, easy and affordable access and peace of mind within that behaviour. Patients are connected with fully accredited private hospitals across the European Union. Clinical information is reviewed in advance. Treatment pathways are defined clearly. Pricing is transparent. The process is organised before travel takes place.

The growth of NHS waiting lists has changed the patient mindset. The rising and often underestimated cost of insurance has reinforced it. Patients no longer accept delay. And increasingly, they are choosing exactly how to avoid it.